Iterum Therapeutics Plc (ITRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cost of Goods | 254 | N/A | N/A | N/A | N/A |
| Gross Profit | -254 | N/A | N/A | N/A | N/A |
| Operating Expenses | 18,696 | 47,468 | 30,383 | 24,537 | 32,126 |
| Operating Income | -18,696 | -47,468 | -30,383 | -24,537 | -32,126 |
| Interest Expense | 2,522 | 1,428 | 2,361 | 5,553 | 15,097 |
| Other Income | -3,316 | 11,138 | -11,389 | -60,769 | -4,040 |
| Pre-tax Income | -24,534 | -37,758 | -44,133 | -90,859 | -51,263 |
| Income Tax | 240 | 613 | 301 | 705 | 743 |
| Net Income Continuous | -24,774 | -38,371 | -44,434 | -91,564 | -52,006 |
| Net Income | $-24,774 | $-38,371 | $-44,434 | $-91,564 | $-52,006 |
| EPS Basic Total Ops | -1.26 | -2.96 | -3.63 | -8.41 | -32.53 |
| EPS Basic Continuous Ops | -1.26 | -2.96 | -3.63 | -8.41 | -32.47 |
| EPS Diluted Total Ops | -1.26 | -2.96 | -3.63 | -8.41 | -32.53 |
| EPS Diluted Continuous Ops | -1.26 | -2.96 | -3.63 | -8.41 | -32.47 |
| EPS Diluted Before Non-Recurring Items | -0.91 | -2.96 | -3.63 | -2.10 | -20.99 |
| EBITDA(a) | $-16,124 | $-43,379 | $-26,245 | $-18,336 | $-21,036 |